The vaccine's trials show it suppresses tumor and potential metastases
Monday, 16 December 2024
Earlier, Director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg told TASS that the vaccine's pre-clinical trials had shown that it suppresses tumor development and potential metastases.